Matt Abernethy, Chief Financial Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 4,940 shares at $116.81 ($577K) on 2021-02-08, disclosed to the SEC on 2021-02-09.
Open-market sale of $577k NBIX by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $116.81 | 2,030 | $237K | 41.1% |
| 2 | $116.81 | 2,030 | $237K | 41.1% |
| 3 | $116.85 | 880 | $103K | 17.8% |
| Total | $116.82 avg | 4,940 | $577K | 100% |
| Filing → |
| NBIX | SELL | 2025-02-12 | $232K | — | Filing → |
| NBIX | SELL | 2025-02-04 | $392K | — | Filing → |
| NBIX | SELL | 2024-08-15 | $2.1M | — | Filing → |